Earnings Summary

Regenxbio Inc’s revenue jumped 9.06% since last year same period to $28.91Mn in the Q3 2023. On a quarterly growth basis, Regenxbio Inc has generated 44.74% jump in its revenue since last 3-months.

Regenxbio Inc’s net profit jumped 22.59% since last year same period to $-61.87Mn in the Q3 2023. On a quarterly growth basis, Regenxbio Inc has generated 14.14% jump in its net profits since last 3-months.

Regenxbio Inc’s net profit margin jumped 29.02% since last year same period to -213.97% in the Q3 2023. On a quarterly growth basis, Regenxbio Inc has generated 40.68% jump in its net profit margins since last 3-months.

Regenxbio Inc’s earning per share (EPS) estimates for the current quarter stand at -1.21 - a 20.39% jump from last quarter’s estimates.

Regenxbio Inc’s earning per share (EPS) estimates for the current year stand at -1.21.

Regenxbio Inc’s earning per share (EPS) jumped 19.43% since last year same period to -1.41 in the Q3 2023. This indicates that the Regenxbio Inc has generated 19.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Regenxbio Inc’s return on assets (ROA) stands at -0.22.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Regenxbio Inc’s return on equity (ROE) stands at -0.56.